Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency ARHCC Library | On Loan, due Friday, May 31, 2024 | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VIC Library Missing | On Loan, due Wednesday, June 12, 2024 | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | On Loan, due Monday, April 8, 2024 | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available |
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
Contents:; The International System for Reporting Serous Fluid Cytopathology: Introduction and Overview of Diagnostic Terminology and Reporting -- Non-diagnostic (ND) and Adequacy -- Negative for Malignancy (NFM) -- Atypia of Undetermined Significance -- Suspicious for Malignancy (SFM) -- Malignant…
A 2020 special report on lung cancer
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency SUR Library | Available |
Contents:; Historical Overview of Occupational Cancer Research -- Genetics and Gene-Environment Interactions -- Mechanisms of Environmental and Occupational Carcinogenesis -- Cancer of the Oral Cavity, Pharynx and Nasopharynx -- Pancreatic Cancer -- Cancers of the Intestine, Liver and Biliary Tract…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Contents:; Chronic Pain and Opioids -- Current Cost of the Opioid Epidemic -- Opioid Use Disorder -- History and Legality of Cannabis -- Overview of the Endocannabinoid System (ECS) -- Cannabinoids and Terpenes -- Synthetic Cannabinoid Pharmaceuticals -- Isolate Cannabinoid Pharmaceuticals -- Medic…
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available |
c.1 BC Cancer Agency KEL Library | On Loan, due Tuesday, October 17, 2023 | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |